Marine Drugs, Volume 18, Issue 6
June 2020 - 57 articles
Streptomycetes are an important source of natural products potentially applicable in the pharmaceutical industry. The biosynthetic genes of these drugs are very often poorly expressed under laboratory cultivation conditions. Antibiotic-resistant mutants exhibit in many cases increased production of natural drugs. In this study, we report the induction of a type II polyketide synthase gene cluster in the marine strain Streptomyces albus subsp. chlorinus through selection of streptomycin resistant mutants, resulting in overproduction of the novel compound fredericamycin C2. The new fredericamycin is structurally related to the potent antitumor drug lead fredericamycin A.
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Cover Story: Streptomycetes are an important source of natural products potentially applicable in the pharmaceutical industry. The biosynthetic genes of these drugs are very often poorly expressed under laboratory cultivation conditions. Antibiotic-resistant mutants exhibit in many cases increased production of natural drugs. In this study, we report the induction of a type II polyketide synthase gene cluster in the marine strain Streptomyces albus subsp. chlorinus through selection of streptomycin resistant mutants, resulting in overproduction of the novel compound fredericamycin C2. The new fredericamycin is structurally related to the potent antitumor drug lead fredericamycin A. View this paper.